Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...

Indian equities extended gains for the seventh straight session on Wednesday, with the BSE Sensex jumping 520.90 points (0.65 ...

The up move in the stock came after the company arm Eugia Pharma Specialities, received final approval from USFDA to ...

Aurobindo Pharma's shares rose nearly 3% after its subsidiary, Eugia Pharma, received USFDA approval to market Dasatinib ...

Mangoceuticals Inc. (NASDAQ:MGRX) is on a mission to rewrite the playbook for men’s performance, health, and vitality. Its pursuit comes at a time when opportunities have become enormous, with patent ...

The global digital health market size is expected to reach USD 946.04 billion by 2030, registering a CAGR of 22.2% from 2025 to 2030, according ...

Alnylam and BridgeBio are competing for people who are switching from Pfizer’s blockbuster ATTR amyloidosis drug tafamidis ...

Xiaomi’s move to target the over ₹20,000 smartphone segment assumes significance as the company once led India’s smartphone ...

The U.S. tech giant's share of China's highly lucrative phone market shrank to 13.7% during the quarter from 15.6% a year earlier, dropping Apple to fifth place in the ranking, according to ...

Amidst the US-China trade tensions, India is strategically positioned to enhance its manufacturing and exports, potentially ...

S4.nontonanimeid.boats Slideshows ...

The latest release by Archos in the Android tablet market is Archos 101f Neon. The tablet comes with a 10.1-inch display IPS screen and resolution of 1024 x 600 pixels. The tablet has a battery of ...